CoraLite®594 Anti-Mouse LAG-3/CD223 Rabbit Recombinant Antibody

LAG-3/CD223 Uni-rAbTM Recombinant Antibody for FC
Cat No. CL594-98167

产品说明书

CloneNo. 241294E11

宿主/亚型

Rabbit / IgG

种属反应性

mouse

应用

FC

CD223, LAG-3, 241294E11, LAG 3, Lag3

缓冲液配方:  PBS and Azide
PBS and Azide
规格价格库存


经过测试的应用

Positive FC detected inAnti-CD3/CD28 treated mouse splenocytes
For other applications, we recommend the unconjugated version of this antibody, 98167-1-PBS

推荐稀释比

应用推荐稀释比
Flow Cytometry (FC)FC : 0.25 ug per 10^6 cells in a 100 µl suspension
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL594-98167 targets LAG-3/CD223 in FC applications and shows reactivity with mouse samples.

经测试应用 FC Application Description
经测试反应性 mouse
免疫原 LAG-3/CD223 fusion protein Eg1220 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 lymphocyte-activation gene 3
别名 CD223, LAG-3, 241294E11, LAG 3, Lag3
计算分子量57 kDa
GenBank蛋白编号NM_008479.2
基因名称 CD223
Gene ID (NCBI) 16768
偶联类型 CoraLite®594 Fluorescent Dye
最大激发/发射波长588 nm / 604 nm
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ61790
储存缓冲液 PBS with 0.09% sodium azide, pH 7.3.
储存条件Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

背景介绍

Lymphocyte activation gene 3 protein (LAG-3), also known as CD223, is a type I transmembrane protein belonging to the immunoglobulin superfamily (PMID: 1692078). It is a CD4-related molecule that binds MHC class II with high affinity (PMID: 1692078; 9159144). LAG-3 is expressed on activated T and NK cells. Besides, natural CD4(+)CD25(+) Tregs express LAG-3 upon activation (PMID: 15485628). LAG-3 negatively regulates T-cell function and homeostasis, and contributes to the suppressor activity of Tregs (PMID: 14644131; 15485628).

实验方案

Product Specific Protocols
FC protocol for CL594 LAG-3/CD223 antibody CL594-98167Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...